Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China.

Autor: Ying, Zhitao1 (AUTHOR), Yang, Haiyan2 (AUTHOR), Guo, Ye3 (AUTHOR), Li, Wenyu4 (AUTHOR), Zou, Dehui5 (AUTHOR), Zhou, Daobin6 (AUTHOR), Wang, Zhao7 (AUTHOR), Zhang, Mingzhi8 (AUTHOR), Wu, Jianqiu9 (AUTHOR), Liu, Hui10 (AUTHOR), Zhang, Pian11 (AUTHOR), Yang, Su11 (AUTHOR), Zhou, Zisong11 (AUTHOR), Zheng, Hongxia11 (AUTHOR), Song, Yuqin1 (AUTHOR) songyuqin622@163.com, Zhu, Jun1 (AUTHOR) zhu-jun2017@outlook.com
Zdroj: Cancer Medicine. Feb2021, Vol. 10 Issue 3, p999-1011. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje